Mina Ryten received an MB, PhD from Cambridge University and UCL and completed academic clinical fellowships in neurology and clinical genetics in London. Since 2017, Dr. Ryten has led her own research group at the UCL Institutes of Neurology and Child Health. At the core of her group’s research is the use of the human brain transcriptome as a genome-wide functional snapshot of an individual’s DNA – a read-out which efficiently and robustly informs our understanding of the genetic origins of adult and pediatric neurological diseases. In the context of Parkinson’s disease, where genetic discoveries are largely made in the form of gene loci, she has generated and used regulatory data across the human brain to link disease risk positions to specific genes. Over the past ten years, Dr. Ryten has thus developed extensive expertise in the generation and use of human brain transcriptomic data with a specific focus on neurodegenerative diseases.